Enhanced albuminuric response to atrial natriuretic peptide in normoalbuminuric patients with Type 1 diabetes mellitus - A pilot study

Diabetic Medicine

Volumn 17, Issue 6, 2000, Pages 463-468

  McKenna, K ^a   Smith, D ^b   Moore, K ^b   Glen, A ^a   Kesson, C M ^a   Thompson, Chris J ^b  

^a VICTORIA INFIRMARY   (United Kingdom)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Atrial natriuretic peptide; Microalbuminuria; Type 1 diabetes mellitus

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; URINE FLOW RATE;

ADULT; ALBUMINURIA; ATRIAL NATRIURETIC FACTOR; BLOOD GLUCOSE; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; PILOT PROJECTS; PLACEBOS; REFERENCE VALUES; URINATION;

EID: 0033913845     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00303.x     Document Type: Article

References (22)

1. 1 Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet 1982; 1: 1430-1432.
2. 2 Ferri C, De Mattia G, Piccoli A, Santucci A, Laurenti O, Balsano F et al. Atrial natriuretic peptide in hypertensive and normotensive diabetic patients. Diabetes Care 1994; 17: 195-200.
3. 3 Bell GM, Bernstein RK, Laragh JH, Atlas SA, James SD, Pecker MS et al. Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci 1989; 77: 177-182.
4. 4 Jungmann E, Graeber S, Scherberich J, Usadel KH. The role of human atrial natriuretic peptide in the pathogenesis of nephropathy in patients with type 1 diabetes mellitus. Med Klinik 1992; 87: 622-625.
5. 5 Firth R, Gafney M, Skelly R, Deegan P, Dowsett D. Is atrial natriuretic peptide associated with glomerular hyperfiltration in diabetics? Diabetologia 1993; 36: A217.
6. 6 Sawicki PT, Heinemann L, Rave K, Hohmann A, Berger M. Atrial natriuretic factor in various stages of nephropathy. J Diab Complications 1988; 2: 207-209.
7. 7 Fioretto P, Sambataro M, Cipollina MR, Giorato C, Carraro A, Opocher G et al. Atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes, 1992; 41: 936-945.
8. 8 Zietse R, Derkx FH, Weimar W, Schalekamp MA. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus. J Am Soc Nephrol 1995; 5: 2057-2066.
9. 9 Prasad N, Clarkson PBM, MacDonald TM, Ryan M, Struthers AD, Thompson CJ. Atrial natriuretic peptide increase urinary albumin excretion in men with type 1 diabetes mellitus and established microalbuminuria. Diabetic Med 1998; 15: 678-682.
10. 2 microglobulin excretion in man. J Hypertension 1988; 6: 783-786.
11. 11 Smits P, Heisbach FMRJ, Jansen TLTA, Thien T, Lutterman JA. Impaired vasodilator response to atrial natriuretic factor in IDDM. Diabetes 1993; 42: 1454-1461.
12. 12 De Chatel R, Toth M, Barna I. Exchangeable body sodium: its relationship with blood pressure and atrial natriuretic factor in patients with diabetes mellitus. J Hypertension 1986; 4: 526-528.
13. 13 Lieberman JS, Parra L, Newton L, Scandling JD, Loon N, Myers BD. Atrial natriuretic peptide and response to changing plasma volume in diabetic nephropathy. Diabetes 1991; 40: 893-901.
14. 14 McKnight J, Roberts G, Sheridan B, Bell PM, Atkinson AB. Basal and stimulated plasma atrial natriuretic factor in patients with and without nephropathy. Diabetic Med 1991; 8: 765-769.
15. 15 Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M. Glomerular size and charge selectivity in insulin dependent diabetes mellitus. Kidney Int 1988; 33: 100-106.
16. 16 Ortola FV, Ballerman BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats; potential mediator of hyperfiltration. J Clin Investigation 1987; 80: 670-674.
17. 17 Perico N, Benigni A, Gabanelli M, Piccinelli M, Rog M, De Riva C et al. Atrial natriuretic and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats. Diabetes 1992; 41: 533-538.
18. 18 Hirata Y, Suzuki Y, Hayakawa H, Suzuki E, Kimura K, Goto A et al. Participation of endogenous atrial natriuretic peptide in the regulation of urinary protein excretion in experimental diabetic rats. Clin Sci 1995; 8: 413-419.
19. 19 Sakamoto K, Kikkawa R, Haneda M, Shigeta Y. Prevention of glomerular hyperfiltration in rats with streptozotocin induced diabetes by an atrial natriuretic peptide receptor antagonist. Diabetologia 1995; 38: 536-542.
20. 20 Weidmann P, Hasler L, Goldinger MP, Lang RE, Uehlinger DE, Shaw S et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Investigation 1986; 77: 734-742.
21. 21 Maack T. Renal clearance and isolated kidney techniques. Kidney Int 1986; 30: 142-151.
22. 22 Zietse R, Derkx FH, Weimar W, Schalekamp MA. Angiotensin converting enzyme inhibition does not correct early defects in renal and vascular permeability in diabetes mellitus. Clin Sci 1998; 94: 165-173.